FluoGuide A/S (STO:FLUO)
Sweden
· Delayed Price · Currency is SEK 42.40
-0.90 (-2.08%)
Apr 29, 2026, 4:37 PM CET
FluoGuide Revenue
In the year 2025, FluoGuide had annual revenue of 220.00K DKK, down -42.86%. FluoGuide had revenue of 54.00K in the quarter ending December 31, 2025, a decrease of -108.42%.
Revenue
220.00K DKK
Revenue Growth
-42.86%
P/S Ratio
2,220.65
Revenue / Employee
32.84K DKK
Employees
7
Market Cap
707.93M SEK
Revenue Chart
* This company reports financials in DKK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Infant Bacterial Therapeutics AB | -1.00K |
| Oncopeptides AB | 71.12M |
| Cantargia AB | 316.70M |
| Medivir AB | 8.51M |
| Xspray Pharma AB | 2.47M |
| Intervacc AB | 20.09M |
| Corline Biomedical AB | 8.59M |
| Genovis AB (publ.) | 129.65M |
FluoGuide News
- 2 months ago - FluoGuide Earnings Call Transcript: Q4 2025 - Transcripts
- 7 months ago - FluoGuide Transcript: Investing in Life Science 2025 - Transcripts
- 4 years ago - FluoGuide Transcript: Investor Call - Transcripts